Prof. Dr. Rainer Fietkau

Lehrstuhl für Strahlentherapie

Treatment response lowers tumor symptom burden in recurrent and/or metastatic head and neck cancer (2020) Hecht M, Hahn D, Wolber P, Hautmann MG, Reichert D, Weniger S, Belka C, et al. Journal article Characteristics of the first 615 patients enrolled in Pacific R: A study of the first real-world data on unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy (2020) Girard N, Fietkau R, Garassino M, Garrido P, Field JK, Peters S, Smit HJM, et al. Conference contribution Senescence Induction by Combined Ionizing Radiation and DNA Damage Response Inhibitors in Head and Neck Squamous Cell Carcinoma Cells (2020) Dobler C, Jost T, Hecht M, Fietkau R, Distel L Journal article Development of an immunological prognostic Signature in metastatic Patients who were treated with Immune Checkpoint Inhibitors as part of the ST-ICI Study (2020) Zhou J, Donaubauer AJ, Frey B, Becker I, Rutzner S, Sun R, Ma H, et al. Conference contribution Effects of Radon-Spa-Therapy on Patients with musculoskeletal Diseases (2020) Becker I, Donaubauer AJ, Klein G, Fournier C, Fietkau R, Frey B, Gaipl U Conference contribution Influence of ex vivo Hyperthermia caused by Warm Water or Microwave Irradiation in a Circulatory System and/or Irradiation on the immunogenic Potential of B16 Melanoma and MCF-7 / MDA-MB-231 Breast Cancer Cells (2020) Hader M, Savcigil DP, Rosin A, Gekle S, Wadepohl M, Fietkau R, Frey B, Gaipl U Conference contribution Accelerated Partial Breast Irradiation: Identification of High Risk Tumors in Early Hormone Receptor-positive Breast Cancer by Macrophage Shift Classification (2020) Schnellhardt S, Erber R, Büttner-Herold M, Rosahl MC, Ott O, Strnad V, Beckmann M, et al. Conference contribution Interstitial PDR-brachytherapy alone or in combination with EBRT for malignancies of the vulvar area: the UK Erlangen experience (2020) Knippen S, Kreppner S, Lotter M, Fietkau R, Strnad V Conference contribution Influence of the ALK Kinase Inhibitors Crizotinib and Alectinib on healthy and malignant Lung Cell Lines in a Combination Therapy with ionizing Radiation (2020) Schultz AK, Jost T, Hecht M, Fietkau R, Distel L Conference contribution Oncological Patients with systemic Lupus Erythematosus have a clear risk of increased Radiation Sensitivity (2020) Schenker H, Schuster B, Hecht M, Fietkau R, Distel L Conference contribution